We would like to thank Janssen for supporting the Poster area

Abstract number Abstract title 
1 ACUTE RHABDOMYOLYSIS SECONDARY TO VYXEOS®
Rocío Zapata Bautista, María Solé Rodríguez, Bianca Díaz Roldán, Francisco Fernández Moreno, Pilar Velarde López de Ayala
View poster
2 AGILE: PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF IVOSIDENIB IN COMBINATION WITH AZACITIDINE IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AND AN IDH1 MUTATION
Pau Montesinos1, Christian Recher2, Ewa Zarzycka3, Vadim Doronin4, Derek McCulloch5, Susana Vives Polo6,  Rodrigo T. Calado7, Jun Ho Jang8, Yasushi Miyazaki9, Jianxiang Wang10, Diego A. Gianolio11, Scott R. Daigle11, Thomas Winkler11, Vickie Zhang11, Peter Paschka12
1Hospital Universitari i Politècnic La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, Madrid, Spain, 2Institut Universitaire du Cancer de Toulouse Oncopole, CHU de Toulouse, Toulouse, France; Université de Toulouse III, Toulouse, France, 3Klinika Hematologii i Transplantologii, Uniwersyteckie Centrum Kliniczne, Gdansk, Poland, 4City Clinical Hospital #40, St Petersburg, Russian Federation, 5Royal Prince Alfred Hospital, Camperdown, Australia, 6ICO Hospital Universitario Germans Trias i Pujol, Josep Carreras Research Institut, Universitat Autònoma de Barcelona, Badalona, Spain, 7Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil, 8Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 9Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 10Institute of Hematology & Hospital of Blood Disease – Peking Union Medical College, Beijing, China, 11Agios Pharmaceuticals, Inc., Cambridge, MA, United States, 12University of Ulm, Ulm, Germany
View poster | View video
3 (CASE REPORT) MULTIPLE RELAPSES OF ACUTE MYELOID LEUKAEMIA POST-TRANSPLANT: CURED WITH PALLIATIVE RADIOTHERAPY
Banuja Srikumar, Mary Taj, Caroline Furness, Henry Mandeville
Paediatric Oncology, Royal Marsden Hospital, 2Paediatric Radiotherapy, Royal Marsden, UK
4 CHRONIC MYELOID LEUKEMIA PATIENTS’ CONCERNS DURING PHASE I OF THE TREATMENT-FREE REMISSION JOURNEY: CONSIDERATIONS BETWEEN PATIENTS AND DOCTORS IN THE DIFFERENT CML ADVOCATES NETWORK REGIONS
Celia Marin, Giora Sharf, Denis Costello
CML Advocates Network, Israel
View posterView video
5 COMBINED TREATMENT WITH SORAFENIB AND 5-AZACYTIDINE FOR NOT INTENSIVE CHEMOTHERAPY CANDIDATES PATIENTS WITH FLT3 MUTATED ACUTE MYELOID LEUKEMIA
María Solé-Rodríguez1, Rocío Zapata-Bautista2, Pilar Velarde López de Ayala2, Susana Ramírez-García, Encarnación Gil-Espárraga
1Hospital Universitario Juan Ramón Jiménez, Huelva, Spain., 2Hospital Universitario Juan Ramón Jiménez, Huelva, Spain
View ePoster
6 COVID-19 AND ITS IMPACT ON SICKLE CELL DISEASE
Rina Ghorpade1, Abhijit Bhattaru1, Ans Ahmad, Ans2
1University of Pennsylvania, Philadelphia, PA, USA, 2Canton Medical Education Foundation, Canton, OH, USA
View ePoster
7 EVALUATION OF THE SAFETY AND EFFICACY OF OFF-LINE EXTRACORPOREAL PHOTOPHERESIS TREATMENT IN PEDIATRIC PATIENTS WITH STEROID-RESISTANT AND STEROID-DEPENDENT ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE
Agnieszka Sobkowiak-Sobierajska, Maksymilian Deręgowski, Jacek Wachowiak
Poland
View poster
8 HAEMATOLOGICAL CHANGES AND MORTALITY IN SARS-COV-2 PATIENTS
Mafalda Urbano1, Elísio Costa2, Catarina Geraldes3
1Coimbra University Hospital  Center (CHUC), 2UCIBIO/REQUIMTE, PORTO4AGEING – Competences Centre on Active and Healthy Ageing, Faculty of Pharmacy, University of Porto, Porto, Portugal, 3Coimbra University Hospital Center (CHUC); Faculty of Medicine, University of Coimbra (FMUC), Coimbra Institute for Clinical and Biomedical Research (iCBR)
View poster | View video
9 IVOSIDENIB IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME: UPDATED ENROLLMENT FOR THE MDS SUBSTUDY
Courtney D. DiNardo1, James M. Foran2, Justin M. Watts3, Eytan M. Stein4, Stéphane de Botton5, Amir T. Fathi6, Gabrielle T. Prince7, Anthony S. Stein8, Richard M. Stone9, Prapti A. Patel10, Gail J. Roboz11, Martha L. Arellano12, Harry P. Erba13, Arnaud Pigneux14, Robert K. Stuart15, Xavier Thomas16, Geoffrey L. Uy17, Abdulafeez Oluyadi18, Ian R. Lemieux18, Hua Liu18, Bin Wu, Bin18, Thomas Winkler18, Guillermo Garcia-Manero1, David A. Sallman19
1University of Texas MD Anderson Cancer Center, Houston, TX, United States, 2Mayo Clinic, Jacksonville, FL, United States, 3University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, United States, 4Memorial Sloan Kettering Cancer Center, New York, NY, United States, 5Institut Gustave Roussy, Villejuif, France, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States, 7Johns Hopkins Hospital, Baltimore, MD, United States, 8City of Hope Medical Center, Duarte, CA, United States, 9Dana-Farber Cancer Institute, Boston, MA, United States, 10University of Texas Southwestern Medical Center, Dallas, TX, United States, 11Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, United States, 12Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States, 13University of Alabama at Birmingham, Birmingham, AL, United States, 14Centre Hospitalier Universitaire de Bordeaux Haut-Lévêque Pessac, France, 15Medical University of South Carolina, Charleston, SC, United States, 16Centre Hospitalier Universitaire de Lyon-Sud, Lyon, France, 17Washington University School of Medicine, St Louis, WA, United States, 18Agios Pharmaceuticals, Inc., Cambridge, MA, United States, 19Moffitt Cancer Center, Tampa, FL, United States
View poster | View video
10 L-ASPARAGINASE NEUROLOGICAL TOXICITY: A SINGLE CASE
Rocío Zapata Bautista, María Solé Rodríguez, Pilar Velarde López de Ayala, Bianca Díaz Roldán, Francisco Fernández Moreno
View poster
11 MIXED-PHENOTYPE ACUTE LEUKEMIA (MPAL): BIOLOGICAL PROFILE, CLINICAL CHARACTERISTIC AND TREATMENT OUTCOMES. REPORT OF A COHORT-BASED STUDY
Alejandro Avendaño Pita, Ana Yeguas Bermejo, María Cortés Rodríguez, Estefanía Pérez López, Ana África Martín López, Mónica Cabrero Calvo, Irene Padilla Conejo, Julio Dávila Valls, Carmen Pérez Martínez, Luis García Martín, Jorge Labrador Gómez, Ana Torres Tienza, Victor Higuero Saavedra, Alba Redondo Guijo, Ivan López Torija, Lucia Guerrero Fernández, María Díez Campelo, Teresa González Martínez, Carmen Chillón Santos, Mª Belén Vidriales Vicente
Hospital Universitario de Salamanca, Spain
12 NEW OPPORTUNITIES FOR ASSAY OF LEUKEMIA INTIATING CELLS (LIC) PARTICIPATING IN POST-TRANSLANT RELAPSE DEVELOPMENT IN THE PATIENTS WITH ACUTE MYELOID LEUKEMIA
Nikolay Mamaev, Alyena Shakirova, Ildar Barkhatov, Tatiana Gindina
View ePoster
13 PREDICTION THE TIME TO FIRST TREATMENT WITH  INTERNATIONAL PROGNOSTIC INDEX FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL-IPI): SINGLE CENTER EXPERIENCE
Sanja Trajkova, Lidjia Cevreska, Aleksandra Pivkova-Veljanovska, Martin Ivanovski, Marija Popova-Labacevska, Nevenka Ridova, Simona Stojanovska, Milce Cvetanovski, Tara Ristovska, Svetlana Stankovik, Svetlana Krstevska Balkanov, Irina Panovska Stavridis
View poster
14 REAL-WORLD HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN 12 COUNTRIES ACROSS WESTERN EUROPE
Madhu Kabra1, Luana Margotto Soares2, Fil Manuguid3
1Otsuka Pharmaceutical Europe Ltd, Wexham, UK, 2IQVIA, Milan, Italy, 3IQVIA, London, UK
View poster
15 SUCCESFUL ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH INTESTINAL ULCERATION AND MASSIVE BLEEDING AS INITIAL MANIFESTATION OF BEHÇET DISEASE ASSOCIATED WITH MYLODYSPLASIA-RELATED CHANGES ACUTE MYELOID LEUKEMIA
Alejandro Avendaño Pita, Luz Gema Roman Molano, Ana África Martín López, Almudena Cabero Martínez, Mónica Baile González, Estefanía Pérez López, Carmén Chillón Santos, Mª Belén Vidriales Vicente, Fernando Muñoz Nuñez, Antonio Chamorro Fernández, MªDolores Caballero Barrigon
Hospital Universitario de Salamanca, Spain
16 TP53 CODON 72 SINGLE NUCLEOTIDE POLYMORPHISM IN CHRONIC LYMPHOCYTIC LEUKEMIA (EXPERIENCE IN ORAN)
Amine Moueden
CHU Oran, Algeria
View poster
17 TRANSIENT SPONTANEOUS REMISSION OF ACUTE MYELOBLASTIC LEUKEMIA
Pilar Velarde Lopez de Ayala, Encarnacion Gil Esparraga, Rocio Zapata Bautista, Karol Gomez Correcha
Hospital Juan Ramon Jimenez, Huelva, España
View poster
18 VENETOCLAX AND POSACONZOLE PLUS STANDARD DOSE CYTARABINE OR AZACITIDINE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
Tran-Der Tan, Lun-Wei Chiou
View ePoster